Relative Strength Chart Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.39 USD | -1.04% | -16.45% | -9.63% |
Jan. 15 | Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM | |
Jan. 15 | Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MYRIAD GENETICS, INC. | Diagnostic & Testing Substances | -1.04% | -16.45% | -9.63% | -38.11% | -56.86% | 1.13B |
- Stock Market
- Equities
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Relative Strength Chart